Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01781949 · ClinicalTrials.gov registry record · NA

The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial

A NA study of Rapid HIV Screening, sponsored by Denver Health and Hospital Authority.

Completed
Registry status
NA
Development phase
76,235
Enrollment target
4
Study locations

NCT01781949 is a NA study of Rapid HIV Screening that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 76,235 participants. The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01781949, a NA study of Rapid HIV Screening, has completed, sponsored by Denver Health and Hospital Authority.

COMPLETED
Registry status
NA
Development phase
76,235 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to evaluate the effectiveness of 3 modern rapid HIV screening methods, including a novel targeted strategy, in urban emergency department settings in the United States.

Conditions Studied

Interventions

  • OTHER A: Nontargeted rapid HIV screening
  • OTHER B: Enhanced targeted rapid HIV screening
  • OTHER C: Traditional targeted rapid HIV screening

Study Locations (4)

California

  • Alameda County Medical Center - Oakland

Colorado

  • Denver Health and Hospital Authority - Denver

Maryland

  • Johns Hopkins University - Baltimore

Ohio

  • University of Cincinnati Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 76,235 participants
Start Date 2014-04
Est. Completion 2018-08-31
Phase NA

What the Registry Record Tells You About NCT01781949

The ClinicalTrials.gov registry entry for NCT01781949 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76,235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rapid HIV Screening appearing as the primary indexed condition, and to 3 interventions - of which A: Nontargeted rapid HIV screening is the first listed.

NCT01781949 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Colorado, Maryland.

Frequently Asked Questions

What is clinical trial NCT01781949 about?

NCT01781949 is a clinical study titled "The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial". The purpose of this study is to evaluate the effectiveness of 3 modern rapid HIV screening methods, including a novel targeted strategy, in urban emergency department settings in the United States.

What is the current status of trial NCT01781949?

This trial is currently completed. It is a NA study. The enrollment target is 76,235 participants. The study started on 2014-04. Estimated completion is 2018-08-31.

What conditions does trial NCT01781949 study?

This clinical trial studies the following conditions: Rapid HIV Screening.

What interventions are being tested in trial NCT01781949?

The interventions under investigation include: A: Nontargeted rapid HIV screening (OTHER), B: Enhanced targeted rapid HIV screening (OTHER), C: Traditional targeted rapid HIV screening (OTHER).

Who is sponsoring clinical trial NCT01781949?

This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01781949 being conducted?

This trial has 4 study locations across California, Colorado, Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.